传强生(JNJ.US)拟收购心血管科技先锋Shockwave Medical(SWAV.US) 以壮大医疗器械版图

智通财经网03-27

智通财经APP获悉，据知情人士透露，强生(JNJ.US)正在与专注于心血管领域的医疗科技公司Shockwave Medical(SWAV.US)进行收购谈判。该交易可能在几周内达成，但如果出现其他竞标者，可能会被搁置。据了解，此举将是这家健康巨头继去年拆分消费者健康业务后为扩展到医疗器械领域所做的最新举措。此次拆分为强生提供了向医疗器械和药品领域扩张的资金。值得一提的是，强生在2022年底收购了...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422931172?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/image/20240327/20240327142502_30666.png?x-oss-process=image/format,jpg/quality,Q_80","is_english":false,"pubTime":"2024-03-27 14:39","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2422931172","market":"hk","top_or_hot":-1,"title":"传强生(JNJ.US)拟收购心血管科技先锋Shockwave Medical(SWAV.US) 以壮大医疗器械版图","media":"智通财经网","content":"<div>\n<p>智通财经APP获悉，据知情人士透露，强生(JNJ.US)正在与专注于心血管领域的医疗科技公司Shockwave  Medical(SWAV.US)进行收购谈判。该交易可能在几周内达成，但如果出现其他竞标者，可能会被搁置。据了解，此举将是这家健康巨头继去年拆分消费者健康业务后为扩展到医疗器械领域所做的最新举措。此次拆分为强生提供了向医疗器械和药品领域扩张的资金。值得一提的是，强生在2022年底收购了...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1093246.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>传强生(JNJ.US)拟收购心血管科技先锋Shockwave Medical(SWAV.US) 以壮大医疗器械版图</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n传强生(JNJ.US)拟收购心血管科技先锋Shockwave Medical(SWAV.US) 以壮大医疗器械版图\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-27 14:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1093246.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，据知情人士透露，强生(JNJ.US)正在与专注于心血管领域的医疗科技公司Shockwave  Medical(SWAV.US)进行收购谈判。该交易可能在几周内达成，但如果出现其他竞标者，可能会被搁置。据了解，此举将是这家健康巨头继去年拆分消费者健康业务后为扩展到医疗器械领域所做的最新举措。此次拆分为强生提供了向医疗器械和药品领域扩张的资金。值得一提的是，强生在2022年底收购了...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1093246.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1093246.html","article_id":"2422931172","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/image/20240327/20240327142502_30666.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422931172","pubTimestamp":1711521588,"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"据知情人士透露，强生正在与专注于心血管领域的医疗科技公司Shockwave Medical进行收购谈判。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1583":"高瓴概念","BK1574":"生物医药B类股","BK1100":"医疗保健设备","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1732800096.USD":"摩根大通环球收益基金A (irc)","JNJ":"强生","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4592":"伊斯兰概念","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4532":"文艺复兴科技持仓","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","BK1222":"医疗保健用品","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK4007":"制药","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","09996":"沛嘉医疗-B","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4082":"医疗保健设备","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","09997":"康基医疗","BK4588":"碎股","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4585":"ETF&股票定投概念","LU0882574055.USD":"富达全球健康医疗A ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4568":"美国抗疫概念","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SWAV":"Shockwave Medical Inc .","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4581":"高盛持仓","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","BK4504":"桥水持仓","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC"},"translate_title":"Johnson & Johnson (JNJ.US) plans to acquire Shockwave Medical (SWAV.US), a pioneer in cardiovascular technology, to expand the map of medical devices","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09997":1,"SWAV":1,"JNJ":1,"09996":1},"content_text":"智通财经APP获悉，据知情人士透露，强生(JNJ.US)正在与专注于心血管领域的医疗科技公司Shockwave  Medical(SWAV.US)进行收购谈判。该交易可能在几周内达成，但如果出现其他竞标者，可能会被搁置。据了解，此举将是这家健康巨头继去年拆分消费者健康业务后为扩展到医疗器械领域所做的最新举措。此次拆分为强生提供了向医疗器械和药品领域扩张的资金。值得一提的是，强生在2022年底收购了Abiomed，该公司生产心脏泵和其他支持肺部和肾脏的技术。据悉，Abiomed曾是Shockwave的投资者。消息公布后，Shockwave周二一度上涨约12%，截至周二收盘，该股市值约118亿美元。根据Shockwave网站上的一段视频，该公司生产的设备可以传递声波来分解动脉中的钙。此外，该公司在上个月公布的2023财年第四季度财报中，营收和利润均超出预期。目前，华尔街分析师将Shockwave的12个月平均目标股价定为262美元。华尔街的最高目标目前为290美元，华尔街最低目标为210美元。在所有接受调查的分析师中，有2位分析师对Shockwave  Medical的评级为正面，一位的评级为中性，没有人的评级为负面。其中，一名市场分析师Myriam Alvarez于今年2月底给予Shockwave“强烈买入”评级，并解释了该公司在医疗设备领域的独特之处。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422931172"}